Literature DB >> 9662052

Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study.

A Jager1, P J Kostense, G Nijpels, R J Heine, L M Bouter, C D Stehouwer.   

Abstract

Microalbuminuria is a strong predictor of cardiovascular disease. The aim of this study was to investigate whether microalbuminuria is part of a cluster of risk factors, the insulin resistance syndrome (IRS), or whether it is only associated with, and presumably a complication of, hypertension and non-insulin-dependent diabetes mellitus (NIDDM). An age-, sex- and glucose tolerance-stratified random sample from a 50-75 year old general population (n = 622) was investigated. The urinary albumin-to-creatinine ratio was measured in an early morning spot urine sample. Microalbuminuria was defined as an albumin-to-creatinine ratio greater than 2.0 mg/ mmol. We considered, as IRS-related variables, fasting hyperinsulinaemia, insulin resistance (IR; calculated from the formula of the homeostasis model assessment), dyslipidaemia, glucose intolerance, hypertension and waist-to-hip ratio (WHR). Dyslipidaemia was defined as levels of HDL-cholesterol in the lowest and/or levels of triglyceride in the highest tertile. Fasting insulin levels, IR and WHR were divided into tertiles; the highest tertiles were compared to the lowest tertiles. Age-, sex- and glucose tolerance-adjusted analyses showed microalbuminuria to be significantly associated with hypertension, NIDDM and WHR. In multiple logistic regression analyses, microalbuminuria showed independent associations with hypertension, NIDDM and WHR, with odds ratios (ORs [95% confidence interval]) of 3.33 (1.86-5.96), 2.26 (1.14-4.48) and 2.49 (1.09-5.70), respectively. No associations were found with impaired glucose tolerance, hyperinsulinaemia, IR or dyslipidaemia. Multiple logistic regression analyses in diabetic and non-diabetic subjects separately showed that microalbuminuria was independently associated only with hypertension (ORs 4.31 and 2.69). In this Caucasian population, microalbuminuria was associated with hypertension, NIDDM and WHR and not with other variables of the IRS. It is therefore likely that microalbuminuria is a complication of hypertension and NIDDM, and not an integral part of the IRS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9662052     DOI: 10.1007/s001250050970

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  Insulin resistance, microalbuminuria, and chronic kidney disease.

Authors:  Pantelis A Sarafidis; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

2.  Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women.

Authors:  A Juutilainen; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  Diabetologia       Date:  2005-12-20       Impact factor: 10.122

3.  Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome.

Authors:  S Bo; L Monge; C Macchetta; G Menato; S Pinach; B Uberti; G Pagano
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

Review 4.  Association of albuminuria and the metabolic syndrome.

Authors:  Kevin Rowley; Kerin O'Dea; James D Best
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

5.  Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients.

Authors:  Erin Rademacher; Michael Mauer; David R Jacobs; Blanche Chavers; Julia Steinke; Alan Sinaiko
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 8.237

6.  Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.

Authors:  Mohamed E Suliman; Mahmut I Yilmaz; Juan J Carrero; Abdul Rashid Qureshi; Mutlu Saglam; Osman M Ipcioglu; Mujdat Yenicesu; Mengli Tong; Olof Heimbürger; Peter Barany; Anders Alvestrand; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 8.237

Review 7.  The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

Authors:  Marcel H A Muskiet; Mark M Smits; Linde M Morsink; Michaela Diamant
Journal:  Nat Rev Nephrol       Date:  2013-12-24       Impact factor: 28.314

Review 8.  Management of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials.

Authors:  H Yki-Järvinen
Journal:  Drugs       Date:  2000-11       Impact factor: 11.431

9.  Diabetes-related symptom distress in association with glucose metabolism and comorbidity: the Hoorn Study.

Authors:  Marcel C Adriaanse; Frans Pouwer; Jacqueline M Dekker; Giel Nijpels; Coen D Stehouwer; Robert J Heine; Frank J Snoek
Journal:  Diabetes Care       Date:  2008-08-26       Impact factor: 19.112

10.  The correlates of urinary albumin to creatinine ratio (ACR) in a high risk Australian aboriginal community.

Authors:  Zaimin Wang; Wendy E Hoy; Zhiqiang Wang
Journal:  BMC Nephrol       Date:  2013-08-16       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.